Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Aus ....Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Australia at the forefront of neuropharmaceutical and neuroscience research. A new research platform will foster collaborations with the pharmaceutical industry both within Australia and overseas. This industrial link will promote a unique post-graduate experience by providing exposure to academic and industrial environments for Australian scientists.Read moreRead less
A VAST potential for ion channel drug discovery. The purpose of this project is to bring innovation into the methods used for identifying and characterising novel carbohydrate-based compounds acting at ion channels. These molecules will have high potential to be developed as highly effective treatments for pain without the unpleasant side-effects associated with current treatments.
Chronic pain and functional impairment following traumatic injury: an investigation into the impact of compensation status and experience. This project will enhance understanding of the impact of the psychosocial factors and the compensation process on recovery from traumatic injury. The project will generate new resources (screening and referral guidelines; educational materials) to improve decision making consistency, client experience, and recovery from road trauma.
Studying the impact of pulsed magnetic fields on neural tissue. This project will determine the optimal parameters of pulsed magnetic fields for treating the ageing and/or damaged brain. The safety features, low cost and compact size of the medical device being investigated maximise compliance and make it relevant to populations in remote and rural areas.
Blood pressure control by neural activation: underlying mechanisms of electric field stimulation and photostimulation of genetically targeted neurones. This project aims to understand how nerve stimulation can be used to treat drug-resistant high blood pressure. The project will lead to new benchmarks for interfacing novel technology with the nervous system and to development and enhancement of commercial devices similar to a cardiac pacemaker for patients with limited treatment options and poor ....Blood pressure control by neural activation: underlying mechanisms of electric field stimulation and photostimulation of genetically targeted neurones. This project aims to understand how nerve stimulation can be used to treat drug-resistant high blood pressure. The project will lead to new benchmarks for interfacing novel technology with the nervous system and to development and enhancement of commercial devices similar to a cardiac pacemaker for patients with limited treatment options and poor prognosis.Read moreRead less
Understanding gender differences in pain: Cellular therapies for animal pain. Understanding gender differences in pain: Cellular therapies for animal pain. This project aims to relieve chronic pain in animals and lay the foundations for future human therapies, using molecular assays, cell technologies and immune/hormonal pain generators. Chronic pain affects females more than males. Establishing the fundamental mechanism in pain, the role of immune signalling and molecular mediators will enable ....Understanding gender differences in pain: Cellular therapies for animal pain. Understanding gender differences in pain: Cellular therapies for animal pain. This project aims to relieve chronic pain in animals and lay the foundations for future human therapies, using molecular assays, cell technologies and immune/hormonal pain generators. Chronic pain affects females more than males. Establishing the fundamental mechanism in pain, the role of immune signalling and molecular mediators will enable true pain-modifying treatments that address pivotal triggers in both genders. This project will then use specially selected stem cells separately targeting arthritic male and female pain and demonstrate novel veterinary chronic pain treatments. Expected outcomes are more effective gender-targeted treatments of pain and the realisation of economic value of molecular assays and cell technologies.Read moreRead less
Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the fu ....Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the future and alleviate their dependence on traditional medications. The devices will also reduce the patients' requirements for medical practitioners, hospital and ambulance services, and will therefore also reduce the financial burden that neurological and epilepsy patients place on the community.Read moreRead less
Conformal Bionics - addressing the challenges in bringing miniaturised implants to the site of therapeutic delivery. Smaller, more sophisticated, lifetime-implantable bionic devices capable of being placed at the site of therapeutic delivery will facilitate new or improved opportunities for treatment of disease. Three critical areas of research aim to be explored in pursuit of this goal will be addressed within this study: introduction of new fabrication materials that enable devices to conform ....Conformal Bionics - addressing the challenges in bringing miniaturised implants to the site of therapeutic delivery. Smaller, more sophisticated, lifetime-implantable bionic devices capable of being placed at the site of therapeutic delivery will facilitate new or improved opportunities for treatment of disease. Three critical areas of research aim to be explored in pursuit of this goal will be addressed within this study: introduction of new fabrication materials that enable devices to conform to the anatomy of the targeted site of therapeutic delivery; improved means of addressing the data and energy transfer needs of devices implanted in confined spaces; and innovation of novel sensors for testing and monitoring of atmospheric conditions within the implant to anticipate and safely manage issues relating to a breach of hermetic encapsulation barriers.Read moreRead less
Resonance: a digital media art work for cooperative group interaction in the rehabilitation of acquired brain injury. The project, titled 'resonance', encompasses the design and development of an interactive multimedia artwork for rehabilitation of Acquired Brain Injury (ABI). The artwork will promote cooperative group interaction between patients, enhancing their motor and cognitive recovery.
Increasing the utility of tetanus toxins by protein engineering. There are a variety of common diseases that are the result of muscular defects. Some of these may be able to be treated with an agent that increases muscle tone, thereby giving benefit to the patient in the alleviation of symptoms. This project aims to use some of the most potent substances known, bacterial toxins, and engineer them to be valuable agents for treatment of certain muscular disorders.